newsfilter
← Latest News
PR Newswire·

AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference

SAN MATEO, Calif., Sept. 6, 2023 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use